Very recently, it has been reported that TRIM21 from human lung endothelial cells displays a modulatory role during the inflammatory response to lipopolysaccharide (LPS), suggesting that TRIM21 is a potential therapeutic target in sepsis-induced endothelial dysfunction [96,97]. The gene discussed is TRIM21; the disease is Sepsis.